http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2386420-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_46191078cf9babcbf6a562e681586f81
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
filingDate 2008-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2010-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0b6abd65b6322487a687e9405f23785
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b0355359222d8b4a0e57ddd0b3be624
publicationDate 2010-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2386420-C1
titleOfInvention Dacryocystitis surgery
abstract FIELD: medicine. ^ SUBSTANCE: invention concerns ophthalmology and covers creation a fistula between lacrimal sac and nasal cavity. The preparation of a surgical area and anaesthesia of internal angle of eye is followed with a square incision of skin and soft tissues. Soft tissues are dissected by a blunt technique, and internal eyelid crease is cut through. A medial wall of the lachrymal sac is separated from periosteum and partially cut off. After separation of the periosteum, on a lateral wall of nose and within a projection of the lachrymal sac, a hole in the bone of the diametre 6-7 mm is cut out with laser which is also used to coagulate a nasal mucosa in a projection of the hole in the bone. The lasing mode for the hole in the bone is 7 Wt, for nasal mucosa - 4-5 Wt. An upper lip of the wound of the medial wall of the lachrymal sac is sutured to the periosteum above the hole in the bone. The surgery is finished by interrupted suturing of the internal eyelid crease and soft tissues in layers. The skin wound is closed with uninterrupted subcuticular suturing. ^ EFFECT: application of the invention restores nonrecurring free patency of lachrymonasal passages, prevents bleeding and eliminates cosmetic defect on facial skin. ^ 2 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2487690-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11202674-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2703141-C1
priorityDate 2008-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409298605
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451216657
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5353356
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID838
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425165935

Total number of triples: 21.